GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 420 filers reported holding GUARDANT HEALTH INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $194,201 | -10.7% | 6,552 | +7.9% | 0.01% | -9.1% |
| Q2 2023 | $217,413 | -63.6% | 6,073 | +1.7% | 0.01% | +37.5% |
| Q4 2021 | $597,519 | -20.6% | 5,974 | -0.8% | 0.01% | -27.3% |
| Q3 2021 | $752,685 | -2.5% | 6,021 | -3.2% | 0.01% | 0.0% |
| Q2 2021 | $772,338 | -15.2% | 6,219 | +4.2% | 0.01% | -21.4% |
| Q1 2021 | $911,168 | +13.4% | 5,969 | -4.3% | 0.01% | +16.7% |
| Q4 2020 | $803,825 | +23.7% | 6,237 | +7.3% | 0.01% | +9.1% |
| Q3 2020 | $650,001 | +35.8% | 5,815 | -1.4% | 0.01% | +37.5% |
| Q2 2020 | $478,667 | +165.6% | 5,900 | +127.9% | 0.01% | +100.0% |
| Q1 2020 | $180,194 | -13.7% | 2,589 | -3.1% | 0.00% | +33.3% |
| Q4 2019 | $208,712 | +21.4% | 2,671 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $171,894 | -58.1% | 2,693 | -43.3% | 0.00% | -57.1% |
| Q2 2019 | $409,809 | +12.6% | 4,747 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $364,095 | +53.4% | 4,747 | -24.8% | 0.01% | +40.0% |
| Q4 2018 | $237,418 | – | 6,316 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |